))
A Cure to Glanzmann's Thrombasthenia on the Horizon?
Manage episode 348772232 series 3422808
Content provided by Glanzmann's Research Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Glanzmann's Research Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Join Peter and Taylor as they speak with Dr. David Wilcox, who has spent close to 30 years researching a cure and advocating in the medical research community for Glanzmann’s.
Tune in to hear how advances in the medical field have brought him close to a cure and how you can help him get even closer.
DISCLOSURE: Dr. David A. Wilcox, Ph.D., is the inventor, President, and Founder of Platelet Targeted Therapeutics, LLC.
He has an equity interest and intellectual property rights in the company.
Dr. Wilcox is an Associate Professor of The Department of Pediatrics HEM/ONC/BMT at the Medical College of Wisconsin. The Content of this PODCAST does not necessarily represent the official views of the Medical College of Wisconsin or its sponsors.
9 episoade
Distribuie
